A detailed history of Aisling Capital Management LP transactions in Poseida Therapeutics, Inc. stock. As of the latest transaction made, Aisling Capital Management LP holds 1,043,267 shares of PSTX stock, worth $9.89 Million. This represents 1.23% of its overall portfolio holdings.

Number of Shares
1,043,267
Previous 1,043,267 -0.0%
Holding current value
$9.89 Million
Previous $3.05 Million 2.07%
% of portfolio
1.23%
Previous 1.33%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 12, 2020

BUY
$8.09 - $16.25 $8.44 Million - $17 Million
1,043,267 New
1,043,267 $9.25 Million

Others Institutions Holding PSTX

About Poseida Therapeutics, Inc.


  • Ticker PSTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 85,775,600
  • Market Cap $813M
  • Description
  • Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...
More about PSTX
Track This Portfolio

Track Aisling Capital Management LP Portfolio

Follow Aisling Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aisling Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Aisling Capital Management LP with notifications on news.